[go: up one dir, main page]

ES540858A0 - Un procedimiento para la preparacion de derivados de espiro-hidantoina - Google Patents

Un procedimiento para la preparacion de derivados de espiro-hidantoina

Info

Publication number
ES540858A0
ES540858A0 ES540858A ES540858A ES540858A0 ES 540858 A0 ES540858 A0 ES 540858A0 ES 540858 A ES540858 A ES 540858A ES 540858 A ES540858 A ES 540858A ES 540858 A0 ES540858 A0 ES 540858A0
Authority
ES
Spain
Prior art keywords
spiro
trione
imidazolidine
indoline
spiral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES540858A
Other languages
English (en)
Other versions
ES8607304A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES8607304A1 publication Critical patent/ES8607304A1/es
Publication of ES540858A0 publication Critical patent/ES540858A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • External Artificial Organs (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
ES540858A 1983-05-25 1985-03-01 Un procedimiento para la preparacion de derivados de espiro-hidantoina Expired ES8607304A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/497,962 US4464380A (en) 1983-05-25 1983-05-25 Imidazolidinedione derivatives

Publications (2)

Publication Number Publication Date
ES8607304A1 ES8607304A1 (es) 1986-06-01
ES540858A0 true ES540858A0 (es) 1986-06-01

Family

ID=23979057

Family Applications (2)

Application Number Title Priority Date Filing Date
ES532736A Expired ES8600764A1 (es) 1983-05-25 1984-05-23 Un procedimiento para la preparacion de derivados de espiro-hidantoina
ES540858A Expired ES8607304A1 (es) 1983-05-25 1985-03-01 Un procedimiento para la preparacion de derivados de espiro-hidantoina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES532736A Expired ES8600764A1 (es) 1983-05-25 1984-05-23 Un procedimiento para la preparacion de derivados de espiro-hidantoina

Country Status (19)

Country Link
US (1) US4464380A (es)
EP (1) EP0127412B1 (es)
JP (1) JPS604183A (es)
KR (1) KR860001869B1 (es)
AT (1) ATE57531T1 (es)
AU (1) AU543916B2 (es)
CA (1) CA1266270A (es)
DE (1) DE3483402D1 (es)
DK (1) DK163924C (es)
ES (2) ES8600764A1 (es)
FI (1) FI78699C (es)
GR (1) GR82020B (es)
HU (1) HU190548B (es)
IE (1) IE57520B1 (es)
IL (1) IL71904A (es)
PH (1) PH21151A (es)
PL (3) PL252850A1 (es)
PT (1) PT78625A (es)
YU (2) YU43931B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0172719B1 (en) * 1984-08-20 1988-09-21 Pfizer Inc. Process for the production as asymmetric hydantoins
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
ATE229948T1 (de) * 1995-10-18 2003-01-15 Hoffmann La Roche Hydroxymethylierung von tocopherolen
NZ512870A (en) 1998-12-19 2003-11-28 Janssen Pharmaceutica Nv Antihistaminic spiro compounds
EP2013216A2 (en) * 2006-02-07 2009-01-14 AstraZeneca AB Novel spiro [imidazolidine-4, 3' -indole] 2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
IE50332B1 (en) * 1979-11-13 1986-04-02 Ici Ltd 1'-substituted-spiro(imidazolidine-4,3'-indoline)-2,2',5-triones,processes for their manufacture and pharmaceutical compositions thereof
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives

Also Published As

Publication number Publication date
FI78699B (fi) 1989-05-31
HUT34194A (en) 1985-02-28
EP0127412A2 (en) 1984-12-05
PT78625A (en) 1984-06-01
DK250084D0 (da) 1984-05-22
ES8607304A1 (es) 1986-06-01
FI78699C (fi) 1989-09-11
ATE57531T1 (de) 1990-11-15
EP0127412A3 (en) 1987-09-02
KR840009101A (ko) 1984-12-24
IL71904A0 (en) 1984-09-30
ES532736A0 (es) 1985-10-16
YU89784A (en) 1987-04-30
YU43931B (en) 1989-12-31
DK163924C (da) 1992-09-14
KR860001869B1 (ko) 1986-10-24
YU212286A (en) 1987-10-31
US4464380A (en) 1984-08-07
PL143290B1 (en) 1988-02-29
FI842079A0 (fi) 1984-05-24
PH21151A (en) 1987-07-30
JPS604183A (ja) 1985-01-10
DE3483402D1 (de) 1990-11-22
GR82020B (es) 1984-12-12
YU43958B (en) 1989-12-31
FI842079A (fi) 1984-11-26
IE57520B1 (en) 1993-05-19
DK163924B (da) 1992-04-21
CA1266270A (en) 1990-02-27
AU2856384A (en) 1984-11-29
PL252850A1 (en) 1985-11-19
IE841294L (en) 1984-11-25
AU543916B2 (en) 1985-05-09
HU190548B (en) 1986-09-29
JPH0573754B2 (es) 1993-10-15
DK250084A (da) 1984-11-26
PL247804A1 (en) 1985-08-13
EP0127412B1 (en) 1990-10-17
IL71904A (en) 1988-01-31
ES8600764A1 (es) 1985-10-16
PL143070B1 (en) 1988-01-30

Similar Documents

Publication Publication Date Title
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
IE790088L (en) Thienohydantoin derivatives
ES540858A0 (es) Un procedimiento para la preparacion de derivados de espiro-hidantoina
AU7767287A (en) New imidazolylguanidine derivatives, processes for their preparation and medicaments containing these compounds
NO893909L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
IE851155L (en) Benzo-(pyrano and thiopyrano)-pyridines
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
MY103765A (en) Azolidinedione derivatives
MY101896A (en) New tetracyclic indole derivatives
IE800672L (en) Spiro-quinolone hydantoins
ES8407050A1 (es) Un derivado de trifluormetil-espiro(imidazolidina-4,3'-indolina)-2,2'5-triona.
FI832959A0 (fi) Spiro/2h-1,4-benzodiazepin-3(5h)4'-piperidin och 3'-pyrrolidin/foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
DK423186A (da) Spiro-(benzofuran-2(3h),1`cycloheptan)-derivater, deres fremstilling og anvendelse samt mellemprodukt til fremstillingen
NO882279D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive endo-bicyklo (2,2,1) heptyl-adenosin-derivater.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519